Sun Pharma Advanced Research Company Ltd

NSE: SPARC · BSE: 532872 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹196.73
Market cap: ₹6,384 Cr
Revenue (annual): ₹1,879 Cr
Net profit (annual): ₹1,553 Cr
P/E (TTM): 4.0×Sector 47.4×
Promoter holding: 65.67%+0.00% QoQ
FII holding: 3.90%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Management Change 3 Financial Results 3 Annual General Meeting 3 Promoter Reclassification 2 Fund Raise 2 Business Update 2 Board Meeting Date 2 Merger & Restructuring 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

25 Jun 2026 18:39 IST BSE

Adverse Business Impact

Sun Pharma Advanced Research Company Adverse Business Impact

Sun Pharma Advanced Research Company terminated its license agreement with CMS Bridging DMCC. The company reports no material impact on its financial position or operations.

Read the filing ↗